Stock listing

NASDAQ:HGSI Human Genome Sciences Inc Stock

Follow Human Genome Sciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:HGSI

$14.24 USD

Close on Aug 3, 2012 · No longer trades

Dec 31, 1997 to last close +43.3% · monthly closes, Dec 31, 1997 – Aug 3, 2012
Lowest – highest close
$0.481 – $112.63 USDSince Dec 31, 1997 · lowest Mar 11, 2009 · highest Mar 1, 2000

Delisted NASDAQ:HGSI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:HGSI
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Human Genome Sciences Inc on 6ix

Decks
8 decks · latest Apr 24, 2012

Decks

DeckKindSlidesDate
Corporate Update (April 2012)Corporate update15 slidesApr 24, 2012
JP Morgan Healthcare Conference 2012Conference29 slidesJan 9, 2012
Investor Presentation (November 2011)Investor deck26 slidesNov 10, 2011
Investor Presentation (September 2011)Investor deck25 slidesSep 8, 2011
Investor Day (April 2011)Investor day59 slidesApr 14, 2011
JPMorgan Healthcare Conference 2011Conference29 slidesJan 10, 2011
American College of Rheumatology (ACR) 74th Annual Scientific Meeting 2010Conference10 slidesNov 8, 2010
Corporate Update (September 2010)Corporate update30 slidesSep 13, 2010

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kevin P Starr
Other companies: MyoKardia Inc (Director · Oct 28, 2015 – Mar 7, 2018 · Past); Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Aug 17, 2015 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Jun 15, 2023 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – Sep 24, 2015 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Feb 19, 2015 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2017 · Past)
Director · May 3, 2007 – Jul 10, 2007 · Past
Augustine Lawlor
Other companies: PRF Technologies Ltd. (Director · Since at least Mar 18, 2026); Cypherpunk Technologies Inc. (Chief Operating Officer · Since at least Jan 20, 2017); Gyre Therapeutics, Inc. (Director · Aug 20, 2015 – Aug 31, 2023 · Past); Globeimmune Inc (Director · Jul 1, 2014 – Mar 18, 2016 · Past); Cardiovascular Systems Inc (Director · Aug 31, 2012 – Apr 27, 2023 · Past)
Director · Oct 10, 2011 – Jul 30, 2012 · Past
David Stump
Other companies: Regenxbio Inc. (Independent Board Member · Since at least Oct 14, 2015); MacroGenics, Inc. (Director · Since at least Oct 9, 2013); Portola Pharmaceuticals Inc (Director · Sep 24, 2015 – Jul 2, 2020 · Past); Dendreon Corp (Director · Jun 2, 2010 – Jan 3, 2014 · Past); Sunesis Pharmaceuticals Inc (Director · Jun 18, 2009 – Jun 30, 2020 · Past)
Exec. Vice President · Mar 10, 2009 – Jul 30, 2012 · Past
Maxine Gowen
Other companies: Passage Bio, Inc. (Chairwoman · Since at least Feb 18, 2021); Aclaris Therapeutics, Inc. (Director · Since at least Jul 2, 2019); Trevena, Inc. (Director · Since at least Jan 30, 2014); Aceragen Inc. (Director · Jan 4, 2015 – Aug 10, 2023 · Past); Akebia Therapeutics, Inc. (Director · Jul 28, 2014 – Jun 5, 2020 · Past)
Director · Feb 15, 2008 – Jul 30, 2012 · Past
Deirdre P. Connelly
Other companies: Sarepta Therapeutics, Inc. (Director · Since at least Sep 12, 2024); Lincoln National Corporation (Director · Since at least May 26, 2016); Macy's Inc (Director · Since at least Jan 1, 2008); Eli Lilly and Company (President, U.S. Operations · Jan 20, 2006 – Jan 27, 2009 · Past)
President & CEO, Director · Jul 30, 2012 – Jul 30, 2012 · Past
John L. LaMattina
Other companies: Ligand Pharmaceuticals Incorporated (Director · Since at least May 31, 2012); Immunome, Inc. (Director · Oct 1, 2020 – Jun 8, 2023 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – Jun 26, 2019 · Past)
Director · May 17, 2012 – Jul 30, 2012 · Past
Adrian Rawcliffe
Other companies: Wave Life Sciences Ltd. (CEO-Partner and Chief Executive Officer · Since at least Feb 1, 2017); Adaptimmune Therapeutics PLC (Chief Executive Officer, Director · Jan 1, 2016 – Feb 20, 2025 · Past)
Chief Financial Officer, Director · Jul 30, 2012 – Jul 30, 2012 · Past
Robert C Young
Other companies: AVEO Pharmaceuticals Inc (Director · May 30, 2012 – Jun 10, 2020 · Past); West Pharmaceutical Services, Inc. (Director · Sep 30, 2011 – Sep 30, 2011 · Past)
Director · May 17, 2012 – Jul 30, 2012 · Past
Curran M. Simpson
Other companies: Regenxbio Inc. (President and Chief Executive Officer, Board Member · Since at least Sep 16, 2015)
Sr. VP, Operations · Mar 10, 2008 – Jul 30, 2012 · Past
Richard J Danzig
Other companies: National Semiconductor Corp (Director · Sep 25, 2009 – Sep 23, 2011 · Past)
Director · May 7, 2009 – Jul 30, 2012 · Past
All 11 people
PersonSeat
James H DavisExec. VP, Gen Counsel & Sec. · Mar 14, 2006 – Jul 30, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Human Genome Sciences Inc.